Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 3 years of Shares Outstanding (Entity) data on file, last reported at $24.7 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.38% year-over-year to $24.7 million in Q1 2026; TTM through Mar 2026 was $24.7 million, a 1.38% increase from a year earlier, with the FY2025 full-year figure at $24.4 million, up 117.11% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $24.7 million, up from $24.4 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ARTV reached as high as $24.7 million in Q1 2026 and fell as low as $811210.0 in Q2 2024.
• Historically, Shares Outstanding (Entity) has averaged $19.2 million across 3 years, with a median of $24.4 million in 2025.
• Across the five-year window, Shares Outstanding (Entity) surged 2905.24% in 2025 and grew 1.38% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $11.3 million in 2024, then jumped by 117.11% to $24.4 million in 2025, then gained by 0.96% to $24.7 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $24.7 million in Q1 2026, $24.4 million in Q4 2025, and $24.5 million in Q3 2025.